Pages that link to "Item:Q2792768"
From MaRDI portal
The following pages link to Assessing additional benefit in noninferiority trials (Q2792768):
Displaying 8 items.
- Sample size for simultaneous testing of rate differences in non-inferiority trials with multiple endpoints (Q961257) (← links)
- Non-inferiority testing for risk ratio, odds ratio and number needed to treat in three-arm trial (Q1727853) (← links)
- Identification of the minimum non-inferior dose in a three-arm non-inferiority trial (Q2131965) (← links)
- Methodological approach to determine minor, considerable, and major treatment effects in the early benefit assessment of new drugs (Q2792760) (← links)
- A framework to assess the value of application of formal criteria to check clinical relevance in RCTs as part of a benefit assessment strategy (Q2792762) (← links)
- Note on simultaneous inferences about non-inferiority and superiority for a primary and a secondary endpoint (Q2889663) (← links)
- On Testing Simultaneously Non‐inferiority in Two Multiple Primary Endpoints and Superiority in at Least One of Them (Q5122886) (← links)
- Re‐Formulating Non‐inferiority Trials as Superiority Trials: The Case of Binary Outcomes (Q5123163) (← links)